Inhaled corticosteroids plus long-acting &bgr;₂-agonists as a combined therapy in asthma

Author： García-Marcos Luis Schuster Antje Barroso Nicolás Cobos

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.1, 2003-01, pp. : 23-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in Asthma and COPD Treatment: Combination Therapy with Inhaled Corticosteroids and Long-Acting &bgr;2-Agonists.

Current Pharmaceutical Design, Vol. 12, Iss. 25, 2006-01 ,pp. : 3261-3279

Bentham Science Publishers

Access to resources Recommend Favorite

Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma: A Pragmatic Trial

By Wilson Edward C.F.

PharmacoEconomics, Vol. 28, Iss. 7, 2010-07 ,pp. : 597-608

Adis International

Access to resources Recommend Favorite

Nocturnal Asthma Uncontrolled by Inhaled Corticosteroids: Theophylline or Long-Acting Agonists?

By Holimon T.D.

Drugs, Vol. 61, Iss. 3, 2001-01 ,pp. : 391-418

Adis International

Access to resources Recommend Favorite

Long-Acting Beta-Agonists and their Association with Inhaled Corticosteroids in COPD

Current Medicinal Chemistry, Vol. 20, Iss. 12, 2013-06 ,pp. : 1477-1495

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of combination long-acting β-2 agonists and inhaled glucocorticosteroids for treatment of asthma

By Kim Dennis Glaum Mark Lockey Richard

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 933-940

Informa Healthcare

Access to resources Recommend Favorite